We are live on ! Find out more
1C

1623 Capital Portfolio holdings

AUM $173M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
-2.64%
1 Year Est. Return
+17.08%
3 Year Est. Return
+11.9%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$162M
AUM Growth
+$1.51M
Cap. Flow
+$12.6M
Cap. Flow %
7.75%
Top 10 Hldgs %
55.81%
Holding
51
New
4
Increased
13
Reduced
3
Closed
8

Top Buys

Rank Stock Value
1
MTCH icon
Match Group
MTCH
+$4.38M
2
VRRM icon
Verra Mobility
VRRM
+$1.34M
3
FDX icon
FedEx
FDX
+$1.18M
4
ADBE icon
Adobe
ADBE
+$555K
5
BR icon
Broadridge
BR
+$552K

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$7.3M
2
VERV
Verve Therapeutics
VERV
+$413K
3
EVBG
Everbridge, Inc. Common Stock
EVBG
+$360K
4
PTCT icon
PTC Therapeutics
PTCT
+$334K
5
AMT icon
American Tower
AMT
+$283K

Sector Composition

Rank Sector Weight
1 Technology 26.17%
2 Financials 16.12%
3 Consumer Discretionary 13.08%
4 Healthcare 9.55%
5 Consumer Staples 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADSK icon
26
Autodesk
ADSK
$49.5B
$1.66M 1.03%
8,900
– –
VRRM icon
27
Verra Mobility
VRRM
$804M
$1.27M 0.78%
+82,470
New +$1.34M
MTCH icon
28
CALL
Match Group
MTCH
$9.19B
$860K 0.53%
18,000
– –
SPIR icon
29
Spire Global
SPIR
$444M
$731K 0.45%
84,594
– –
ETWO
30
DELISTED
E2open Parent Holdings
ETWO
$714K 0.44%
117,697
– –
AMPS
31
DELISTED
Altus Power
AMPS
$689K 0.43%
62,619
– –
PEN icon
32
Penumbra
PEN
$12.7B
$539K 0.33%
2,843
– –
BMRN icon
33
BioMarin Pharmaceuticals
BMRN
$11.6B
$508K 0.31%
5,994
– –
DXCM icon
34
DexCom
DXCM
$31.5B
$425K 0.26%
5,272
– –
IAS
35
DELISTED
Integral Ad Science
IAS
$422K 0.26%
58,231
– –
FRSH icon
36
Freshworks
FRSH
$3.14B
$414K 0.26%
31,898
– –
NARI
37
DELISTED
Inari Medical, Inc. Common Stock
NARI
$410K 0.25%
5,647
– –
SMAR
38
DELISTED
Smartsheet Inc.
SMAR
$385K 0.24%
11,203
– –
PODD icon
39
Insulet
PODD
$11.5B
$334K 0.21%
1,458
– –
CDLX icon
40
Cardlytics
CDLX
$21.7M
$306K 0.19%
3,258
– –
EVBG
41
DELISTED
Everbridge, Inc. Common Stock
EVBG
$286K 0.18%
9,257
-10,973
-54% -$360K
ISRG icon
42
Intuitive Surgical
ISRG
$127B
$266K 0.16%
+1,418
New +$305K
RARE icon
43
Ultragenyx Pharmaceutical
RARE
$2.45B
$240K 0.15%
5,789
-1,442
-20% -$74.1K
EQIX icon
44
Equinix
EQIX
$101B
– –
-11,105
Closed -$7.3M
NTLA icon
45
Intellia Therapeutics
NTLA
$1.49B
– –
-4,117
Closed -$213K
PTCT icon
46
PTC Therapeutics
PTCT
$5.68B
– –
-8,335
Closed -$334K
QTRX icon
47
Quanterix
QTRX
$164M
– –
-12,198
Closed -$197K
SES icon
48
SES AI
SES
$203M
– –
-33,193
Closed -$130K
VERV
49
DELISTED
Verve Therapeutics
VERV
– –
-26,999
Closed -$413K
MYNA
50
DELISTED
Mynaric AG American Depository Shares
MYNA
– –
-41,111
Closed -$281K
1
2
3

Similar funds

GA
Greytown Advisors Miami, Florida $170M AUM 15.94% 1-Year Est. Return
CBC
Coombe, Bender & Co Ellenville, New York $170M AUM 15.56% 1-Year Est. Return
WWP
Walden Wealth Partners Beachwood, Ohio $179M AUM
IGWM
ICA Group Wealth Management Denver, Colorado $167M AUM 18.57% 1-Year Est. Return
HWMA
Heritage Wealth Management (Arizona) Phoenix, Arizona $180M AUM
RA
Regis Acquisition Denver, Colorado $164M AUM 15.81% 1-Year Est. Return
SWM
Solano Wealth Management Fairfield, California $183M AUM 14.53% 1-Year Est. Return
SVI
Strategic Vision Investment Hong Kong $157M AUM 125.87% 1-Year Est. Return

1623 Capital's Q3 2022 Portfolio in Review

As of Q3 2022, 1623 Capital held 51 positions worth $162M, up 0.94% from $160M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

1623 Capital deployed $12.6M of net new capital in Q3 2022, opening 4 new positions and adding to 13 existing holdings. Its largest new stake was Match Group: 69,700 shares worth $3.33M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Everbridge, Inc. Common Stock, an estimated $360K trimmed.

  • 1623 Capital's largest Q3 2022 buy was Match Group: 69,700 shares worth $3.33M.
  • 1623 Capital added most to FedEx in Q3 2022, an estimated $1.18M increase.
  • 1623 Capital's biggest Q3 2022 reduction was Everbridge, Inc. Common Stock, cutting an estimated $360K.
  • 1623 Capital fully exited Equinix in Q3 2022, selling an estimated $7.3M.
  • 1623 Capital's ten largest holdings make up 56% of its $162M portfolio in Q3 2022.
  • 1623 Capital opened 4 new positions and closed 8 in Q3 2022.
  • 1623 Capital's portfolio value rose 0.94% quarter-over-quarter to $162M.

Based on 1623 Capital's 13F filing for Q3 2022, filed 14 Nov 2022.